Unisphere Establishment’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Unisphere Establishment's PFE Position: Q1 2026 in Review
Unisphere Establishment held its Pfizer (PFE) position steady in Q1 2026 at 14,650,000 shares worth $411M. The position accounts for 3.46% of the portfolio, ranked #10.
Unisphere Establishment first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Unisphere Establishment held 14,650,000 shares of Pfizer worth $411M as of Q1 2026.
- Unisphere Establishment left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 3.46% of Unisphere Establishment's portfolio in Q1 2026, its #10 holding.
- Unisphere Establishment first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Unisphere Establishment's 13F filing for Q1 2026, filed 14 May 2026.